Hi-Impacts

About

Q&A

What is Hi-Impacts' primary focus?

Hi-Impacts is a medical device company focused on developing novel therapies designed to transform the standard of care for orthopedic, vascular, urologic, and other diseases with noninvasive, non-drug therapy.

What technology has Hi-Impacts developed?

Hi-Impacts has developed a proprietary acoustic pulse technology (APT), also known as shock wave technology, specifically designed for medical applications.

What are the typical applications of Hi-Impacts' APT interventions?

APT interventions from Hi-Impacts are often used to treat inflammatory and ischemic diseases, as well as for fracture fusion.

What are the key features of Hi-Impacts' patented APT device?

Hi-Impacts' patented APT device is compact, cost-effective, and specially designed for treatments on large areas (50x350 mm), allowing for treatment anywhere in the body in a short time.

When was Hi-Impacts founded?

Hi-Impacts was founded in June 2012.

Where is Hi-Impacts headquartered?

Hi-Impacts is headquartered in Ra'anana, Center District, Israel.

What is the current employee count at Hi-Impacts?

Hi-Impacts has 1-10 employees.

In which sector does Hi-Impacts primarily operate?

Hi-Impacts' primary sector is Health Tech & Life Sciences, with specific focus on Medical Devices and Medical Treatment & Therapeutics.

Team · 2

Eddie Papirov

Founder · Founder & CEO

Itzhak Friedman

Founder · Founder & CSO

Sectors & technology

Highlights

Tags